HomeVRCA • NASDAQ
add
Verrica Pharmaceuticals Inc
Previous close
$4.48
Day range
$4.47 - $4.76
Year range
$3.28 - $9.82
Market cap
79.37M USD
Avg Volume
146.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 5.09M | 1,380.23% |
Operating expense | 8.12M | -17.83% |
Net income | -8.07M | 50.17% |
Net profit margin | -158.56 | 96.63% |
Earnings per share | -0.51 | 74.66% |
EBITDA | -6.83M | 38.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.15M | -34.93% |
Total assets | 47.13M | -12.94% |
Total liabilities | 22.39M | -65.02% |
Total equity | 24.74M | — |
Shares outstanding | 17.18M | — |
Price to book | 3.11 | — |
Return on assets | -39.45% | — |
Return on capital | -77.06% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.07M | 50.17% |
Cash from operations | -4.59M | 71.42% |
Cash from investing | — | — |
Cash from financing | 13.64M | -65.40% |
Net change in cash | 9.05M | -61.28% |
Free cash flow | -1.56M | 86.59% |
About
Founded
2013
Headquarters
Website
Employees
76
